Buy Acb Stock | FHD 2025 |

: Global medical cannabis now accounts for 81% of total revenue and 95% of adjusted gross profit , with medical margins holding steady at 69% . Market Sentiment & Ratings

Professional outlooks on ACB are mixed, balancing its medical leadership against broader sector risks. buy acb stock

Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? : Global medical cannabis now accounts for 81%

As of April 28, 2026, Aurora Cannabis (ACB) is trading at , reflecting a 19.12% decline year-to-date . The company is currently executing a strategic shift to prioritize high-margin global medical cannabis markets over lower-margin consumer segments. Aurora Cannabis Inc (ACB) -19.12% since Jan 2, 2026 Closed: 4:00 PM • Disclaimer After hours: 7:30 PM Apr 27, 2026 Mkt cap$271.06M CAD 52-wk high6.67 P/E ratio- 52-wk low3.07 Div yield- Financial Performance & Health As of April 28, 2026, Aurora Cannabis (ACB)

: The company maintains a "cannabis debt-free" balance sheet with $154.4 million in cash as of December 31, 2025.